Asymptomatic Prostate Cancer Metastasis in Rectal Mucosa Revealed by 18F-PSMA-1007 PET/CT

被引：1
|
作者：
Wang, Shu [1 ]
Cheng, Zhiming [1 ]
Du, Bulin [1 ]
Li, Yaming [1 ,2 ]
Li, Xuena [1 ,2 ]
机构：
[1] China Med Univ, Hosp 1, Dept Nucl Med, Shenyang, Peoples R China
[2] China Med Univ, Hosp 1, Dept Nucl Med, 155 Nanjing Northern St, Shenyang 110001, Liaoning, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 04期
关键词：
metastasis; prostate cancer; PSMA PET/CT; rectal mucosa; SUVmax;
D O I：
10.1097/RLU.0000000000004560
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Prostate cancer metastasis to the rectal mucosa, a relatively rare metastatic site, leads to a higher clinical stage and poorer prognosis. A 65-year-old man with prostate cancer underwent F-18-prostate-specific membrane antigen (PSMA) PET/CT for staging. Intense F-18-PSMA uptake occurred at the primary lesion, bladder, adjacent seminal vesicle, and rectum. PET/CT imaging revealed increased homogeneous round activity of the rectal wall. The final diagnosis was prostate cancer metastasis to the rectal mucosa. This case suggested that F-18-PSMA PET/CT may assist in locating rare metastases of prostate cancer, with potential value for early staging.
引用
收藏
页码：354 / 355
页数：2
相关论文
共 50 条
  • [21] 18F-PSMA-1007 PET/CT in Biochemically Relapsed PCa
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 17N - 17N
  • [22] Concomitant laryngeal squamous cell carcinoma and prostate cancer on 18F-FDG PET/CT and 18F-PSMA-1007 PET/CT
    Pu, Yongzhu
    Xie, Ran
    Deng, Zhiyong
    Chen, Long
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [23] Non-prostate uptake on 18F-PSMA-1007 PET/CT: a case of myeloma
    Veerasuri, Sowmya
    Redman, Stewart
    Graham, Richard
    Meehan, Chris
    Little, David
    BJR CASE REPORTS, 2021, 7 (02):
  • [24] An exploratory study of unexplained concentration of 18F-PSMA-1007 in the bladder for prostate cancer PET/CT imaging
    Dang, Jun
    Yao, Yutang
    Li, Yingchun
    Tan, Xiaofei
    Ye, Zhenyan
    Zhao, Yi
    Qing, Shiwei
    Kou, Ying
    Jiang, Xiao
    Lu, Hao
    Chen, Shirong
    Zhao, Meng
    Cheng, Zhuzhong
    FRONTIERS IN MEDICINE, 2023, 10
  • [25] Recurrent Prostate Cancer Diagnostics with 18F-PSMA-1007 PET/CT: A Systematic Review of the Current State
    Saule, Laura
    Radzina, Maija
    Liepa, Mara
    Roznere, Lilita
    Lioznovs, Andrejs
    Ratniece, Madara
    Mamis, Edgars
    Vjaters, Egils
    DIAGNOSTICS, 2022, 12 (12)
  • [26] Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT
    Ji, Xiaowei
    Wang, Ling
    Lin, Jie
    Tang, Kun
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E74 - E76
  • [27] Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Hu, Yuan
    Wang, Peng
    Dai, Wenli
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [28] Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Yuan Hu
    Peng Wang
    Wenli Dai
    BMC Pulmonary Medicine, 23
  • [29] 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer
    Liu, Bo-Le
    Hong, Jun-Jie
    Tang, Kun
    Lin, Jie
    Zheng, Xiang-Wu
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : E355 - E357
  • [30] Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
    Hvittfeldt, Erland
    Bjoersdorff, Mimmi
    Brolin, Gustav
    Minarik, David
    Svegborn, Sigrid L.
    Oddstig, Jenny
    Tragardh, Elin
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2022, 42 (06) : 443 - 452
12345